The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Review of the real-world prevalence of mHSPC, nmCRPC, mCRPC, and gene alterations associated with HRR in prostate cancer (PC).
 
Neal D. Shore
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Merck; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Louisa Oliver
No Relationships to Disclose
 
Irene Shui
Employment - Genzyme; Merck
Stock and Other Ownership Interests - Merck; Sanofi
Research Funding - Merck; Merck; Merck; Merck; Sanofi
Travel, Accommodations, Expenses - Merck; Sanofi
 
Alicia Gayle
Employment - AstraZeneca
 
On Yee Wong
No Relationships to Disclose
 
Jeri Kim
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sarah Payne
No Relationships to Disclose
 
Sameer R. Ghate
Employment - Merck Sharp & Dohme; Novartis
Stock and Other Ownership Interests - Advaxis (I); Bellicum Pharmaceuticals (I); Bellicum Pharmaceuticals (I); Calithera Biosciences (I); Idera (I); Mannkind; Provectus